Details for New Drug Application (NDA): 022018
✉ Email this page to a colleague
The generic ingredient in LAMIVUDINE AND ZIDOVUDINE is lamivudine; zidovudine. There are twenty-nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the lamivudine; zidovudine profile page.
Summary for 022018
Tradename: | LAMIVUDINE AND ZIDOVUDINE |
Applicant: | Pharmacare |
Ingredient: | lamivudine; zidovudine |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 150MG;300MG | ||||
Approval Date: | Mar 17, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription